Melanoma Tumors Use Interferon-Gamma Mutations to Fight Immunotherapy
Thursday, September 22, 2016 - 13:02
in Health & Medicine
Melanoma tumors use genetic mutations in a prominent immune response pathway to resist the immunotherapy ipilimumab, researchers from The University of Texas MD Anderson Cancer Center report in the journal Cell.